Cargando…
Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
Autores principales: | Dementieva, I, Trekova, N, Sandrikov, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099724/ http://dx.doi.org/10.1186/cc2604 |
Ejemplares similares
-
Experience of NovoSeven administration in management of coagulopathic bleedings after surgical interventions with extracorporeal circulation
por: Dzybinskaya, E, et al.
Publicado: (2006) -
Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
por: Michalska, G, et al.
Publicado: (2007) -
Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007) -
Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004) -
Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
por: Miatech, Jennifer L, et al.
Publicado: (2021)